rs879036238
|
|
PERIVENTRICULAR NODULAR HETEROTOPIA 8
|
C |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs137852824
|
|
Proprotein Convertase 1 3 Deficiency
|
A |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs137852821
|
|
Proprotein Convertase 1 3 Deficiency
|
T |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs201871537
|
|
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs1558087795
|
|
PERIVENTRICULAR NODULAR HETEROTOPIA 8
|
G |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1558087712
|
|
PERIVENTRICULAR NODULAR HETEROTOPIA 8
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs137852823
|
|
Proprotein Convertase 1 3 Deficiency
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs137852822
|
|
Proprotein Convertase 1 3 Deficiency
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs6235
|
|
Insulin measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion.
|
23263489 |
2013 |
rs6235
|
|
Insulin measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
|
21873549 |
2011 |
rs2072590
|
|
ovarian neoplasm
|
|
0.720 |
GeneticVariation
|
GWASCAT |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
rs2072590
|
|
ovarian neoplasm
|
T |
0.720 |
GeneticVariation
|
GWASCAT |
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
20852632 |
2010 |
rs958476
|
|
Lupus Nephritis
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
rs958476
|
|
Lupus Erythematosus, Systemic
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
rs843750
|
|
Body Height
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs6755777
|
|
ovarian neoplasm
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
rs6755777
|
|
Ovarian Mucinous Adenocarcinoma
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
rs6755777
|
|
Ovarian Serous Adenocarcinoma
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
rs631844
|
|
Maculopapular Lesion
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs631844
|
|
Epilepsy
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs6235
|
|
Fasting blood glucose measurement
|
G |
0.700 |
GeneticVariation
|
GWASCAT |
Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies.
|
23903356 |
2013 |
rs6235
|
|
Body mass index
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs6235
|
|
Lean body mass
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genomics of body fat percentage may contribute to sex bias in anorexia nervosa.
|
30593698 |
2019 |
rs6235
|
|
Body mass index
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
rs6234
|
|
Body mass index
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
|
29273807 |
2018 |